DalsnaFinance

Inhibikase Therapeutics Inc $IKT

Health Care

Russell 2000

Create a scorecard

$2.50

-0.02 (-0.79%)

As of Sep 5, 2026, 5:36 PM EDT

Price history

Loading chart…

Inhibikase Therapeutics Inc (IKT) is trading down at $2.50 (-0.79%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

IPO: December 23, 2020 · $10.00 offering · NASDAQ · View IPO details →

Recent News

No recent news mentioning Inhibikase Therapeutics Inc in our feed yet.

More Health Care stocks

AZN AstraZeneca
ILMN Illumina
A Agilent Technologies
ABBV AbbVie
ABT Abbott Laboratories
ALGN Align Technology
AMGN Amgen
BAX Baxter International

Browse all companies →